Better performance of PIVKA-II for detecting hepatocellular carcinoma in patients with chronic liver disease with normal total bilirubin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Better performance of PIVKA-II for detecting hepatocellular carcinoma in patients with chronic liver disease with normal total bilirubin

Published:2023-02-28 Issue:8 Volume:29 Page:1359-1373
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:
Short-container-title:World J Gastroenterol

Author:

Qian Xiang-Jun,Wen Zhu-Mei,Huang Xiao-Ming,Feng Hui-Juan,Lin Shan-Shan,Liu Yan-Na,Li Sheng-Cong,Zhang Yu,Peng Wen-Guang,Yang Jia-Rui,Zheng Zhe-Yu,Zhang Lei,Zhang Da-Wei,Lu Feng-Min,Liu Li-Juan,Pan Wei-Dong

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference38 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

3. Sorafenib in Advanced Hepatocellular Carcinoma

4. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Female and Diabetes are risk factors for Alpha-fetoprotein and Vitamin K deficiency or antagonist -II negative in Hepatocellular Carcinoma;2024-03-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP